Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
Thumbnail

GE HealthCare stands on its own

GE has completed the spinoff of its healthcare business, and GE HealthCare began trading as its own entity on the Nasdaq Jan. 4.

Thumbnail

Industry group pushes for cannabis screenings in surgery

The American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine) has released new guidelines surrounding cannabis use in relation to surgery, advocating for all patients undergoing procedures with anesthesia to be screened for cannabis use.

 

Thumbnail

GAO appoints 7 new members to health IT advisory committee

Seven members have been added to the Health Information Technology Advisory Committee (HITAC), a group tasked with improving the quality and access of health IT by the Government Accountability Office (GAO).

 

Medicare money payment physician

Healthcare groups react to Medicare cuts remaining in $1.7T spending bill

The American Medical Association said its members are "extremely disappointed and dismayed" that Congress did not act in time. The Medical Group Management Association shared a similar message. 

Tripledemic shortages: Walgreens, CVS limit sale of children’s medications

A wave of infections across the United States has led to a run on certain over-the-counter medications, and some retailers are limiting purchases to deal with the seasonal demand.

Claire Ernst, director of government affairs, Medical Group Management Association (MGMA), explains the list of priorities for the association. These include staving off the large, planned 2023 Medicare reimbursement cuts, fighting for continuation of reimbursements for telehealth, and revamping prior authorizations.

VIDEO: Top priorities for the Medical Group Management Association in 2022

Claire Ernst, director of government affairs, Medical Group Management Association (MGMA), explains the list of priorities for the association, include staving off the large Medicare reimbursement cuts, continuation of telehealth reimbursements, and revamping prior authorizations. 

FDA adds diabetes medicine to drug shortage list

A diabetes treatment drug, Mounjaro, has been added to the Food and Drug Administration’s (FDA) list of drug shortages.

Thumbnail

Chicago physician indicted in $9.5M healthcare fraud conspiracy

Benjamin T. Toh, of Chicago faces up to 10 years in prison and a $250,000 fine.

Displaying 481 - 488 of 2772

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup